Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cocrystal Pharma, Inc.

1.60
+0.02001.27%
Volume:17.56K
Turnover:29.61K
Market Cap:16.28M
PE:-0.93
High:1.79
Open:1.64
Low:1.60
Close:1.58
Loading ...
Jun 15, 2020

Major Issues Report

8-K - Current report
Jun 08, 2020

Major Issues Report

8-K - Current report
May 13, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 12, 2020

Correspondence

CORRESP [Cover] - Correspondence
May 11, 2020

Correspondence

CORRESP [Cover] - Correspondence
May 11, 2020

Major Issues Report

Current report, items 7.01 and 9.01
May 04, 2020

Correspondence

CORRESP [Cover] - Correspondence
Apr 22, 2020

Major Issues Report

Current report, items 1.01, 7.01, and 9.01
Apr 20, 2020

Major Issues Report

Current report, items 5.02 and 9.01
Mar 30, 2020

Major Issues Report

Current report, items 2.02, 8.01, and 9.01
Mar 27, 2020

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 13, 2020

Major Issues Report

Current report, items 1.01, 1.02, 5.02, 7.01, 8.01, and 9.01
Mar 10, 2020

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Mar 09, 2020

Major Issues Report

Current report, items 7.01 and 9.01
Mar 06, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Mar 04, 2020

Major Issues Report

Current report, items 1.01, 7.01, and 9.01
Mar 04, 2020

Major Issues Report

Current report, items 7.01 and 9.01
Mar 03, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 28, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 27, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals